Factors associated with the presence of circulating active tissue factor and activated factor XI in stable angina patients

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
Michał ZąbczykAnetta Undas

Abstract

Circulating active tissue factor (TF) and activated factor XI (FXIa) have been detected in subgroups of acute coronary syndromes (ACSs) and stable angina patients. We sought to evaluate the determinants of active TF and FXIa in stable angina patients. We studied 124 consecutive stable angina patients. Recent ACS, atrial fibrillation, and anticoagulant therapy were the exclusion criteria. Plasma active TF and FXIa were determined by measuring the response to inhibitory antibodies. T helper 1 lymphocyte (Th1) and Th2 responses were assessed in plasma by interleukin (IL)-4, IL-6, IL-8, IL-10, IL-18, interferon-γ, and tumor necrosis factor-α, oxidative stress by 8-isoprostaglandin F(2α) (8-iso-PGF(2α)), and coagulation by prothrombin fragments F1+2 (F1+2) and free TF pathway inhibitor (f-TFPI). TF and FXIa activity were detected in 25 (20.2%) and 49 (39.5%) stable angina patients, respectively. Both factors were found in 23 (18.5%) patients. Patients with detectable TF or FXIa had higher F1+2, 8-iso-PGF(2α), IL-6, but not other cytokines, and lower f-TFPI (all P < 0.001) compared with the remainder. There were no intergroup differences with regard to cardiovascular risk factors or medication. Multivariate analysis showed that F1+2 ...Continue Reading

References

Aug 1, 1995·Circulation·E FalkV Fuster
May 29, 2002·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Ø HetlandD W T Nilsen
Apr 3, 2004·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Annelie SiegemundLothar Engelmann
Apr 10, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Simone J H WieldersTheo Lindhout
May 1, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Nigel Mackman
Dec 1, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Anetta UndasKenneth G Mann
Jan 5, 2005·Journal of the American College of Cardiology·Valerio SanguigniFrancesco Violi
Jun 29, 2005·Circulation·Peter Libby, Pierre Theroux
May 5, 2006·Seminars in Thrombosis and Hemostasis·Harold R RobertsDougald M Monroe
Jul 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·Donna L PedicordYuval Blat
Jan 25, 2008·Thrombosis and Haemostasis·Saulius ButenasKenneth G Mann
Apr 9, 2009·Blood·Dmitri V KravtsovDavid Gailani
May 30, 2009·Journal of cardiology·Epaminondas Zakynthinos, Nikolitsa Pappa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

© 2022 Meta ULC. All rights reserved